Terms: = Lymphoma AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712
35 results:
1. Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.
Kubota Y; Gu X; Terkawi L; Bodo J; Przychodzen BP; Awada H; Williams N; Gurnari C; Kawashima N; Aly M; Durmaz A; Mori M; Ponvilawan B; Kewan T; Bahaj W; Meggendorfer M; Jha BK; Visconte V; Rogers HJ; Haferlach T; Maciejewski JP
Nat Commun; 2024 Feb; 15(1):1832. PubMed ID: 38418452
[TBL] [Abstract] [Full Text] [Related]
2. IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies.
Parrondo RD; Iqbal M; Von Roemeling R; Von Roemeling C; Tun HW
Front Immunol; 2023; 14():1239082. PubMed ID: 37954584
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive genomic profiling reveals molecular subsets of
Johnson SM; Haberberger J; Galeotti J; Ramkissoon L; Coombs CC; Richardson DR; Foster MC; Duncan D; Montgomery ND; Ferguson NL; Zeidner JF
Leuk Lymphoma; 2024 Feb; 65(2):209-218. PubMed ID: 37921062
[TBL] [Abstract] [Full Text] [Related]
4. Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes.
Zhao Y; Guo J; Zhao S; Wang R; Wu D; Chang C
Leuk Lymphoma; 2024 Jan; 65(1):100-108. PubMed ID: 37865969
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
Jelloul FZ; Quesada AE; Yang RK; Li S; Wang W; Xu J; Tang G; Yin CC; Fang H; El Hussein S; Khoury J; Bassett RL; Garcia-Manero G; Manasanch EE; Orlowski RZ; Qazilbash MH; Patel KP; Medeiros LJ; Lin P
Mod Pathol; 2023 Jun; 36(6):100166. PubMed ID: 36990279
[TBL] [Abstract] [Full Text] [Related]
6. Radon-222 and Leukemia.
Harley NH; Leslie LA
Health Phys; 2023 Jun; 124(6):475-477. PubMed ID: 36880974
[TBL] [Abstract] [Full Text] [Related]
7. Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.
Aldea M; Tagliamento M; Bayle A; Vasseur D; Vergé V; Marinello A; Danlos FX; Blanc-Durand F; Bernard E; Cerbone L; Mosele MF; Renneville A; Hadoux J; Loriot Y; Sakkal M; Vozy A; Sarkozy C; Smolenschi C; Nicotra C; Martin-Romano P; Boccon-Gibod C; Habza W; Lazarovici J; Ponce S; Hollebecque A; Marzac C; Lacroix L; Barlesi F; André F; Besse B; Rouleau E; Italiano A; Micol JB
JCO Precis Oncol; 2023 Mar; 7():e2200583. PubMed ID: 36862966
[TBL] [Abstract] [Full Text] [Related]
8. The eukaryotic translation initiation factor eIF4E reprograms alternative splicing.
Ghram M; Morris G; Culjkovic-Kraljacic B; Mars JC; Gendron P; Skrabanek L; Revuelta MV; Cerchietti L; Guzman ML; Borden KLB
EMBO J; 2023 Apr; 42(7):e110496. PubMed ID: 36843541
[TBL] [Abstract] [Full Text] [Related]
9. Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes.
Tinsley-Vance SM; Ali NA; Ball S; Aguirre LE; Jain AG; Hussaini MO; Chan O; Kuykendall A; Sweet K; Lancet J; Padron E; Sallman DA; Komrokji RS
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):355-359. PubMed ID: 36813626
[TBL] [Abstract] [Full Text] [Related]
10. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
[TBL] [Abstract] [Full Text] [Related]
11. Predictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis.
Hu C; Wang X
Leuk Lymphoma; 2022 Oct; 63(10):2336-2351. PubMed ID: 35543621
[TBL] [Abstract] [Full Text] [Related]
12. Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma.
Vaios EJ; Batich KA; Buckley AF; Dunn-Pirio A; Patel MP; Kirkpatrick JP; Goudar R; Peters KB
Oncotarget; 2022; 13():576-582. PubMed ID: 35359747
[TBL] [Abstract] [Full Text] [Related]
13. Aberrant RNA splicing and therapeutic opportunities in cancers.
Yamauchi H; Nishimura K; Yoshimi A
Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550
[TBL] [Abstract] [Full Text] [Related]
14. u2af1 expression is a novel and independent prognostic indicator of childhood T-lineage acute lymphoblastic leukemia.
Zhang P; Zhang Y; Li X; Ying P; Tang Y
Int J Lab Hematol; 2021 Aug; 43(4):675-682. PubMed ID: 33314767
[TBL] [Abstract] [Full Text] [Related]
15. Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis.
Castillo-Tokumori F; Talati C; Al Ali N; Sallman D; Yun S; Sweet K; Padron E; Lancet J; Komrokji R; Kuykendall AT
Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):e956-e960. PubMed ID: 32778513
[TBL] [Abstract] [Full Text] [Related]
16. Complex landscape of alternative splicing in myeloid neoplasms.
Hershberger CE; Moyer DC; Adema V; Kerr CM; Walter W; Hutter S; Meggendorfer M; Baer C; Kern W; Nadarajah N; Twardziok S; Sekeres MA; Haferlach C; Haferlach T; Maciejewski JP; Padgett RA
Leukemia; 2021 Apr; 35(4):1108-1120. PubMed ID: 32753690
[TBL] [Abstract] [Full Text] [Related]
17. Defining Acute Myeloid Leukemia Ontogeny in Older Patients.
Melody M; Kuykendall A; Sallman D; Al Ali N; Zhang L; Talati C; Padron E; Sweet K; Extermann M; List A; Lancet J; Komrokji R
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):312-315. PubMed ID: 32139296
[TBL] [Abstract] [Full Text] [Related]
18. Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes.
Madan V; Li J; Zhou S; Teoh WW; Han L; Meggendorfer M; Malcovati L; Cazzola M; Ogawa S; Haferlach T; Yang H; Koeffler HP
Am J Hematol; 2020 Feb; 95(2):133-143. PubMed ID: 31680297
[TBL] [Abstract] [Full Text] [Related]
19. Genetic Polymorphisms in Inflammatory and Other Regulators in Gastric Cancer: Risks and Clinical Consequences.
Rudnicka K; Backert S; Chmiela M
Curr Top Microbiol Immunol; 2019; 421():53-76. PubMed ID: 31123885
[TBL] [Abstract] [Full Text] [Related]
20. Investigation of Intracellular Delivery of NuBCP-9 by Conjugation with Oligoarginines Peptides in MDA-MB-231 Cells.
Wang W; Suga T; Hagimori M; Kuroda N; Fuchigami Y; Kawakami S
Biol Pharm Bull; 2018; 41(9):1448-1455. PubMed ID: 30175779
[TBL] [Abstract] [Full Text] [Related]
[Next]
